Opens in a new tab

Predictable delivery starts with the right capabilities

Consistent recruitment, strong retention and audit-ready data. Delivered together on every study.

Why sponsors trust NeuroClnx to deliver

Every sponsor needs fast recruitment, stronger retention and high-quality data. The challenge is often achieving all three at the same time.

Many studies experience recruitment delays, participant dropout, inconsistent data quality or operational variability between sites. These issues create additional oversight, increase trial costs and threaten critical programme milestones. 

NeuroClnx helps reduce that risk.

Request a feasibility discussion

Conditions we diagnose

24 hours

From green light to first patient visit

78%

Of participants complete the study

Zero

We’ve never had a critical audit finding

Recruitment performance

Recruitment delay is still one of the most common causes of timeline slippage in clinical research. When enrolment falls behind, sponsors face higher costs, later milestones and pressure to activate more sites.

NeuroClnx is built to recruit quickly, and to do it repeatedly.

  • The #1 recruiting UK site in a global Phase 3 Alzheimer’s programme, 48% of total recruitment across 12 competing UK sites
  • Over 4,500 participants actively engaged with us
  • 24 hours from green light to first patient visit
  • 98% of participants would recommend us to friends and family
  • Capacity for up to 45 participants a day at our clinics

Faster recruitment protects study timelines, brings key milestones forward and takes pressure off the wider site network.

Request a feasibility discussion

Participant retention

Long-term brain health studies ask a lot of people. Caregiver involvement, repeated assessments, demanding visit schedules, and participants managing progressive neurological or psychiatric conditions. Retention depends on specialist clinical oversight and sustained contact.

We’ve invested in the facilities and infrastructure that keeps people engaged. Experienced Principal Investigators work alongside 14 dedicated patient liaison and study coordination specialists who support participants and their carers throughout the study journey.

  • 78% average retention following randomisation, measured across 10 years of studies
  • Over 98% of participants would recommend us to friends and family
  • 100% retention achieved in selected programmes

Fewer dropouts mean more complete datasets and greater confidence in your study outcomes.

Request a feasibility discussion

Data quality and compliance

Strong recruitment only counts if it produces reliable, usable data.

We pair clinician-led teams with disciplined operational process, so quality holds from first patient to final dataset. That means reliable study conduct, less rework, and data that stands up to scrutiny.

  • Multiple successful sponsor and regulatory audits across major programmes
  • Governance, compliance and quality systems built around GCP and ICH E6
  • Consistent focus on data integrity and fast query resolution

With less rework, we deliver greater confidence in the data and fewer surprises late in delivery.

Request a feasibility discussion

Operational resilience

Sites need to perform when recruitment pressure builds, protocols get demanding or a study hits a critical phase.

NeuroClnx brings more than 25 years of brain health experience and a multidisciplinary team of 45 research specialists across physician, nursing, psychology, pharmacy, patient liaison and study coordination.

That depth means delivery never rests on one or two individuals. Cover is planned, capacity flexes, and the study keeps its momentum.

Resilience you can plan around, across the full study lifecycle.

Request a feasibility discussion
We look for sites that are committed to quality, collaborative with sponsors, proactive in recruitment, and committed to patient safety and wellbeing. NeuroClnx deliver on all of that.

NeuroClnx conducts clinical trials
in a range of areas including:

Expertise that reduces delivery risk

Complex eligibility criteria, specialist assessments, caregiver involvement and long study durations all raise operational risk. Capability matters, but so does knowing the clinical reality behind the protocol.

See how our experience across Alzheimer’s, Parkinson’s, mood disorders and psychedelic research supports delivery.

Built for scrutiny

Governance, regulatory compliance and recruitment practice are where sponsor confidence is won or lost.

See how we recruit, how we stay compliant, and what our audit history looks like.

Discuss your next study

Whether you’re assessing sites for an upcoming study, testing recruitment feasibility, or looking for reliable support on a milestone-critical programme, our team is here to help.

Talk to us about study requirements, patient populations, site capacity, timelines and delivery expectations.

Get in touch to learn how we can help your study stay on track.

"*" indicates required fields

I’m interested in*
Preferred method of contact*
Keep me informed

Latest news

View all